HPV-RELATED MALIGNANCY
Clinical trials for HPV-RELATED MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED MALIGNANCY trials appear
Sign up with your email to follow new studies for HPV-RELATED MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood test could spare cancer patients harsh radiation
Disease control Recruiting nowThis study is testing if a blood test that looks for tiny bits of cancer DNA can help doctors decide which patients need radiation after surgery for HPV-related throat cancer. The goal is to see if some patients can safely delay radiation or receive a shorter course of treatment.…
Matched conditions: HPV-RELATED MALIGNANCY
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Scientists test 'Living Drug' to fight HPV cancers
Disease control Recruiting nowThis study is testing a new personalized treatment for advanced cancers caused by HPV. Doctors take a patient's own immune cells, modify them in a lab to better target the cancer, and infuse them back to try to shrink tumors before standard therapy like chemo or surgery. The goal…
Matched conditions: HPV-RELATED MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for advanced cervical cancer: trial tests drug combo after standard treatment fails
Disease control Recruiting nowThis study is for people with advanced cervical cancer that has returned or spread and is no longer responding to the immunotherapy drug pembrolizumab. It will test if adding a new investigational drug called PRGN-2009 to pembrolizumab is more effective and safe than continuing p…
Matched conditions: HPV-RELATED MALIGNANCY
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Engineered immune cells target HPV cancers in new trial
Disease control Recruiting nowThis study is testing a new gene therapy for people with advanced cancers caused by HPV. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack HPV-infected cancer cells, and then infuse them back into the patient. The goal is to see if thi…
Matched conditions: HPV-RELATED MALIGNANCY
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC